BioCentury
ARTICLE | Clinical News

ProCord regulatory update

September 20, 2004 7:00 AM UTC

FDA granted Orphan Drug designation to ProCord, an autologous incubated macrophage therapy, to improve the motor and sensory neurological outcome in cases of acute spinal cord injury (SCI). ProCord is...